What is Atomo?
Atomo operates at the intersection of healthcare, life sciences, and health economics, utilizing sophisticated machine learning algorithms to synthesize disparate data sets. By identifying populations with the highest unmet medical needs, the company provides actionable intelligence that enables stakeholders to optimize treatment pathways and resource allocation. With three decades of domain expertise, Atomo has established itself as a critical partner for organizations seeking to navigate the complexities of modern health outcomes research. The company platform serves as a bridge between raw clinical data and strategic decision-making, effectively transforming fragmented information into a cohesive roadmap for improved patient health outcomes.
How much funding has Atomo raised?
Atomo has raised a total of $2.6M across 1 funding round:
Angel/Seed
$2.6M
Angel/Seed (2019): $2.6M, investors not publicly disclosed
Key Investors in Atomo
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for Atomo?
Following this major strategic investment, Atomo is poised to accelerate its enterprise-level expansion. The capital will likely be deployed to enhance the company predictive modeling capabilities and broaden its reach within the global life sciences sector. As the healthcare industry continues to prioritize data-driven interventions, Atomo is strategically positioned to capitalize on the shift toward personalized medicine. Future growth will likely focus on deepening integration with existing clinical workflows and expanding the scope of its analytics to cover a wider array of chronic conditions, thereby solidifying its role as a leader in the health economics and outcomes research landscape.
See full Atomo company page
